Alnylam Pharmaceuticals
ALNY
#637
Rank
A$55.70 B
Marketcap
A$417.20
Share price
-1.02%
Change (1 day)
-6.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: A$688.99 AUD on 2025-10-20

Lowest end of day price: A$5.54 AUD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2026

Annual Stock Price Performance

Year Performance
2026-25.20%
2025 70.21%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$213.21 0.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$62.12-1.40%๐Ÿ‡ซ๐Ÿ‡ท France
A$896.09-0.58%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.56-0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.45 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.78-0.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$47.79-0.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$105.12-0.78%๐Ÿ‡บ๐Ÿ‡ธ USA